Burney Company’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Sell |
5,142
-1,060
| -17% | -$346K | 0.06% | 250 |
|
|
2025
Q1 | $1.67M | Sell |
6,202
-19,536
| -76% | -$5.28M | 0.06% | 236 |
|
|
2024
Q4 | $6.06M | Buy |
25,738
+4,791
| +23% | +$1.13M | 0.21% | 100 |
|
|
2024
Q3 | $5.76M | Sell |
20,947
-4,492
| -18% | -$1.24M | 0.2% | 119 |
|
|
2024
Q2 | $6.18M | Sell |
25,439
-1,620
| -6% | -$394K | 0.24% | 105 |
|
|
2024
Q1 | $4.04M | Buy |
27,059
+21,325
| +372% | +$3.19M | 0.15% | 157 |
|
|
2023
Q4 | $1.1M | Buy |
+5,734
| New | +$1.1M | 0.05% | 314 |
|